{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:17:05Z","timestamp":1793171825273,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008291","name":"College of Medicine, University of Nebraska Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008291","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.biomaterials.2019.119669","type":"journal-article","created":{"date-parts":[[2019,12,7]],"date-time":"2019-12-07T12:43:27Z","timestamp":1575722607000},"page":"119669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Rilpivirine-associated aggregation-induced emission enables cell-based nanoparticle tracking"],"prefix":"10.1016","volume":"231","author":[{"given":"Insiya Z.","family":"Mukadam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jatin","family":"Machhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Herskovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmudul","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim D.","family":"Oleynikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson R.","family":"Blomberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Svechkarev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M.","family":"Mohs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanta","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoEllyn","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santhi","family":"Gorantla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jered","family":"Garrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard E.","family":"Gendelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavesh D.","family":"Kevadiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biomaterials.2019.119669_bib1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.idc.2014.06.001","article-title":"Antiretroviral therapy: current drugs","volume":"28","author":"Pau","year":"2014","journal-title":"Infect. Dis. Clin. N. Am."},{"issue":"3","key":"10.1016\/j.biomaterials.2019.119669_bib2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1086\/314623","article-title":"Combination antiretroviral therapy and recent declines in AIDS incidence and mortality","volume":"179","author":"Vittinghoff","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biomaterials.2019.119669_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.biomaterials.2017.10.023","article-title":"Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles","volume":"151","author":"Zhou","year":"2018","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119669_bib4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41467-018-02885-x","article-title":"Creation of a long-acting nanoformulated dolutegravir","volume":"9","author":"Sillman","year":"2018","journal-title":"Nat. Commun."},{"issue":"60","key":"10.1016\/j.biomaterials.2019.119669_bib5","doi-asserted-by":"crossref","first-page":"8371","DOI":"10.1039\/C8CC04708A","article-title":"ProTide generated long-acting abacavir nanoformulations","volume":"54","author":"Lin","year":"2018","journal-title":"Chem. Commun. (Camb)"},{"issue":"5","key":"10.1016\/j.biomaterials.2019.119669_bib6","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1128\/AAC.01529-09","article-title":"Pharmacokinetics and disposition of rilpivirine (TMC278) nanosuspension as a long-acting injectable antiretroviral formulation","volume":"54","author":"van 't Klooster","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.biomaterials.2019.119669_bib7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/COH.0000000000000002","article-title":"Long-acting injectable antiretrovirals for HIV treatment and prevention","volume":"8","author":"Spreen","year":"2013","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119669_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/COH.0000000000000160","article-title":"Long-acting rilpivirine for HIV prevention","volume":"10","author":"Jackson","year":"2015","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"3","key":"10.1016\/j.biomaterials.2019.119669_bib9","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejpb.2009.03.006","article-title":"Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment","volume":"72","author":"Baert","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119669_bib10","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1038\/s41467-019-10366-y","article-title":"Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice","volume":"10","author":"Dash","year":"2019","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.biomaterials.2019.119669_bib11","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1365-2796.2011.02457.x","article-title":"HIV reservoirs and the possibility of a cure for HIV infection","volume":"270","author":"Palmer","year":"2011","journal-title":"J. Intern. Med."},{"issue":"10","key":"10.1016\/j.biomaterials.2019.119669_bib12","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/QAD.0b013e328353f3f1","article-title":"HIV reservoirs: pathogenesis and obstacles to viral eradication and cure","volume":"26","author":"Chun","year":"2012","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.biomaterials.2019.119669_bib13","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/jac\/dks533","article-title":"Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts","volume":"68","author":"Hocqueloux","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119669_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrmicro.2015.5","article-title":"HIV reservoirs: what, where and how to target them","volume":"14","author":"Churchill","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119669_bib15","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.antiviral.2009.09.016","article-title":"HIV reservoirs, latency, and reactivation: prospects for eradication","volume":"85","author":"Dahl","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.biomaterials.2019.119669_bib16","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.biomaterials.2018.09.018","article-title":"Bioimaging predictors of rilpivirine biodistribution and antiretroviral activities","volume":"185","author":"Ottemann","year":"2018","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119669_bib17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.7150\/thno.22764","article-title":"Multimodal theranostic nanoformulations permit magnetic resonance bioimaging of antiretroviral drug particle tissue-cell biodistribution","volume":"8","author":"Kevadiya","year":"2018","journal-title":"Theranostics"},{"issue":"21","key":"10.1016\/j.biomaterials.2019.119669_bib18","doi-asserted-by":"crossref","first-page":"11718","DOI":"10.1021\/acs.chemrev.5b00263","article-title":"Aggregation-induced emission: together we shine, united we soar!","volume":"115","author":"Mei","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biomaterials.2019.119669_bib19","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1039\/b904665h","article-title":"Aggregation-induced emission: phenomenon, mechanism and applications","volume":"29","author":"Hong","year":"2009","journal-title":"Chem. Commun. (Camb)"},{"issue":"11","key":"10.1016\/j.biomaterials.2019.119669_bib20","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1039\/c1cs15113d","article-title":"Aggregation-induced emission","volume":"40","author":"Hong","year":"2011","journal-title":"Chem. Soc. Rev."},{"issue":"31","key":"10.1016\/j.biomaterials.2019.119669_bib21","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1002\/adma.201401356","article-title":"Aggregation-induced emission: the whole is more brilliant than the parts","volume":"26","author":"Mei","year":"2014","journal-title":"Adv. Mater."},{"issue":"25","key":"10.1016\/j.biomaterials.2019.119669_bib22","doi-asserted-by":"crossref","first-page":"22074","DOI":"10.1021\/acsami.7b00845","article-title":"Photocontrolled SiRNA delivery and biomarker-triggered luminogens of aggregation-induced emission by up-conversion NaYF4:Yb3+Tm3+@SiO2 nanoparticles for inducing and monitoring stem-cell differentiation","volume":"11","author":"Wong","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biomaterials.2019.119669_bib23","first-page":"245","article-title":"Macrophage activation induced by lymphocyte mediators","volume":"194","author":"David","year":"1975","journal-title":"Acta Endocrinol. Suppl."},{"key":"10.1016\/j.biomaterials.2019.119669_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12977-014-0133-5","article-title":"Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages","volume":"12","author":"Arainga","year":"2015","journal-title":"Retrovirology"},{"key":"10.1016\/j.biomaterials.2019.119669_bib25","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J","article-title":"Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia","volume":"18","author":"Foley","year":"1965","journal-title":"Cancer"},{"issue":"6163","key":"10.1016\/j.biomaterials.2019.119669_bib26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/332469a0","article-title":"Quantitative infectivity assay for HIV-1 and-2","volume":"332","author":"Nara","year":"1988","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119669_bib27","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jsps.2014.04.007","article-title":"Drug nanocrystals: a way toward scale-up","volume":"24","author":"Raghava Srivalli","year":"2016","journal-title":"Saudi Pharm. J."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119669_bib28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.virol.2006.08.012","article-title":"Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophages","volume":"358","author":"Dou","year":"2007","journal-title":"Virology"},{"issue":"No. 12","key":"10.1016\/j.biomaterials.2019.119669_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1351\/PAC-REP-10-09-31","article-title":"Standards for photoluminescence quantum yield measurements in solution","volume":"83","author":"Brouwer","year":"2011","journal-title":"Pure Appl. Chem."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119669_bib30","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1107\/S0021889808042726","article-title":"OLEX2: a complete structure solution, refinement and analysis program","volume":"42","author":"Dolomanov","year":"2009","journal-title":"J. Appl. Crystallogr."},{"issue":"Pt 1","key":"10.1016\/j.biomaterials.2019.119669_bib31","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1107\/S0108767307043930","article-title":"A short history of SHELX","volume":"64","author":"Sheldrick","year":"2008","journal-title":"Acta Crystallogr. A"},{"issue":"Pt 1","key":"10.1016\/j.biomaterials.2019.119669_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. C Struct. Chem."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2019.119669_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.biomaterials.2019.119669_bib34","doi-asserted-by":"crossref","first-page":"119441","DOI":"10.1016\/j.biomaterials.2019.119441","article-title":"Synthesis of a long acting nanoformulated emtricitabine ProTide","volume":"222","author":"Soni","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2019.119669_bib35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jconrel.2019.09.001","article-title":"Creation of a long-acting rilpivirine prodrug nanoformulation","volume":"311\u2013312","author":"Hilaire","year":"2019","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119669_bib36","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7150\/thno.39847","article-title":"Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues","volume":"10","author":"Kevadiya","year":"2020","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119669_bib37","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s11481-011-9298-z","article-title":"Human immunodeficiency virus type 1 endocytic trafficking through macrophage bridging conduits facilitates spread of infection","volume":"6","author":"Kadiu","year":"2011","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"6","key":"10.1016\/j.biomaterials.2019.119669_bib38","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2217\/nnm.11.27","article-title":"Macrophage endocytic trafficking of antiretroviral nanoparticles","volume":"6","author":"Kadiu","year":"2011","journal-title":"Nanomedicine"},{"issue":"17","key":"10.1016\/j.biomaterials.2019.119669_bib39","doi-asserted-by":"crossref","first-page":"9504","DOI":"10.1128\/JVI.01557-14","article-title":"Endosomal trafficking of nanoformulated antiretroviral therapy facilitates drug particle carriage and HIV clearance","volume":"88","author":"Guo","year":"2014","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.biomaterials.2019.119669_bib40","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1128\/JVI.02010-06","article-title":"Human immunodeficiency virus type 1 pathobiology studied in humanized BALB\/c-Rag2-\/-gammac-\/- mice","volume":"81","author":"Gorantla","year":"2007","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.biomaterials.2019.119669_bib41","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells","volume":"9","author":"Siliciano","year":"2003","journal-title":"Nat. Med."},{"issue":"4915","key":"10.1016\/j.biomaterials.2019.119669_bib42","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.2665081","article-title":"The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4","volume":"245","author":"Schnittman","year":"1989","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.biomaterials.2019.119669_bib43","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.celrep.2018.07.079","article-title":"HIV-1-Infected CD4+ T cells facilitate latent infection of resting CD4+ T cells through cell-cell contact","volume":"24","author":"Agosto","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.biomaterials.2019.119669_bib44","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.colsurfb.2018.08.016","article-title":"Comparative studies on amphotericin B nanosuspensions prepared by a high pressure homogenization method and an antisolvent precipitation method","volume":"172","author":"Zhou","year":"2018","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.biomaterials.2019.119669_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cej.2011.12.044","article-title":"Liquid antisolvent precipitation and stabilization of nanoparticles of poorly water soluble drugs in aqueous suspensions: recent developments and future perspective","volume":"181\u2013182","author":"Thorat","year":"2012","journal-title":"Chem. Eng. J."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119669_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0896-8446(98)00129-6","article-title":"Supercritical antisolvent precipitation of micro- and nano-particles","volume":"15","author":"Reverchon","year":"1999","journal-title":"J. Supercrit. Fluids"},{"issue":"5","key":"10.1016\/j.biomaterials.2019.119669_bib47","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1021\/acs.cgd.7b00013","article-title":"Crystallization-driven formation of diversified assemblies for supramolecular poly(lactic acid)s in solution","volume":"17","author":"Chang","year":"2017","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.biomaterials.2019.119669_bib48","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jconrel.2017.08.031","article-title":"Exploring intracellular fate of drug nanocrystals with crystal-integrated and environment-sensitive fluorophores","volume":"267","author":"Gao","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biomaterials.2019.119669_bib49","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1134\/S0006350914020079","article-title":"On mechanisms of fluorescence quenching by water","volume":"59","author":"Dobretsov","year":"2014","journal-title":"Biophysics"},{"issue":"39","key":"10.1016\/j.biomaterials.2019.119669_bib50","doi-asserted-by":"crossref","first-page":"9094","DOI":"10.1021\/jp5021017","article-title":"Aggregation effects on the optical emission of 1,1,2,3,4,5-hexaphenylsilole (HPS): a QM\/MM study","volume":"118","author":"Zhang","year":"2014","journal-title":"J. Phys. Chem. A"},{"issue":"15","key":"10.1016\/j.biomaterials.2019.119669_bib51","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1097\/QAD.0000000000000408","article-title":"The importance of monocytes and macrophages in HIV pathogenesis, treatment, and cure","volume":"28","author":"Campbell","year":"2014","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.biomaterials.2019.119669_bib52","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1586\/14737159.2013.819216","article-title":"Monocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of disease","volume":"13","author":"Lameijer","year":"2013","journal-title":"Expert Rev. Mol. Diagn"},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119669_bib53","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1517\/17425247.2011.559457","article-title":"Cell-mediated drug delivery","volume":"8","author":"Batrakova","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"issue":"5320","key":"10.1016\/j.biomaterials.2019.119669_bib54","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1126\/science.276.5320.1857","article-title":"Macrophages as a source of HIV during opportunistic infections","volume":"276","author":"Orenstein","year":"1997","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.biomaterials.2019.119669_bib55","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1021\/acsnano.6b06245","article-title":"Phenotype determines nanoparticle uptake by human macrophages from liver and blood","volume":"11","author":"MacParland","year":"2017","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119669_bib56","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nmat3780","article-title":"Imaging macrophages with nanoparticles","volume":"13","author":"Weissleder","year":"2014","journal-title":"Nat. Mater."},{"issue":"6","key":"10.1016\/j.biomaterials.2019.119669_bib57","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1084\/jem.128.6.1309","article-title":"The interaction of human monocytes and lymphocytes","volume":"128","author":"Cline","year":"1968","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biomaterials.2019.119669_bib58","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-62703-336-7_6","article-title":"Methods for isolation and identification of nanoparticle-containing subcellular compartments","volume":"991","author":"Nowacek","year":"2013","journal-title":"Methods Mol. Biol."},{"issue":"10","key":"10.1016\/j.biomaterials.2019.119669_bib59","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.4049\/jimmunol.178.10.6404","article-title":"Cytoskeletal protein transformation in HIV-1-infected macrophage giant cells","volume":"178","author":"Kadiu","year":"2007","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119669_bib60","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cellimm.2008.08.005","article-title":"Tunneling nanotubes (TNT) are induced by HIV-infection of macrophages: a potential mechanism for intercellular HIV trafficking","volume":"254","author":"Eugenin","year":"2009","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.biomaterials.2019.119669_bib61","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fimmu.2018.00043","article-title":"Tunneling nanotubes: intimate communication between myeloid cells","volume":"9","author":"Dupont","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119669_bib62","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/s41467-018-04088-w","article-title":"A mobile endocytic network connects clathrin-independent receptor endocytosis to recycling and promotes T cell activation","volume":"9","author":"Compeer","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119669_bib63","first-page":"75","article-title":"Long-acting agents for HIV infection: biological aspects, role in treatment and prevention, and patient's perspective","volume":"40","author":"Rusconi","year":"2017","journal-title":"New Microbiol."},{"issue":"12","key":"10.1016\/j.biomaterials.2019.119669_bib64","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1016\/j.xphs.2016.09.015","article-title":"Past, present, and future drug delivery systems for antiretrovirals","volume":"105","author":"Kirtane","year":"2016","journal-title":"J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.biomaterials.2019.119669_bib65","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1080\/09540121003668102","article-title":"Improving adherence and clinical outcomes through an HIV pharmacist's interventions","volume":"22","author":"Ma","year":"2010","journal-title":"AIDS Care"},{"issue":"6","key":"10.1016\/j.biomaterials.2019.119669_bib66","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/ni.3152","article-title":"HIV reservoirs as obstacles and opportunities for an HIV cure","volume":"16","author":"Chun","year":"2015","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119669_bib67","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.biomaterials.2013.10.009","article-title":"Programmed nanoparticles for combined immunomodulation, antigen presentation and tracking of immunotherapeutic cells","volume":"35","author":"Heo","year":"2014","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119669_bib68","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/74464","article-title":"Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells","volume":"18","author":"Lewin","year":"2000","journal-title":"Nat. Biotechnol."},{"issue":"43","key":"10.1016\/j.biomaterials.2019.119669_bib69","doi-asserted-by":"crossref","first-page":"17972","DOI":"10.1021\/ja3064588","article-title":"Real-time monitoring of cell apoptosis and drug screening using fluorescent light-up probe with aggregation-induced emission characteristics","volume":"134","author":"Shi","year":"2012","journal-title":"J. Am. Chem. Soc."},{"issue":"15","key":"10.1016\/j.biomaterials.2019.119669_bib70","doi-asserted-by":"crossref","first-page":"12189","DOI":"10.1021\/acsami.7b12320","article-title":"Tetraphenylethylene-based AIE-active probes for sensing applications","volume":"10","author":"La","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"45","key":"10.1016\/j.biomaterials.2019.119669_bib71","doi-asserted-by":"crossref","first-page":"23726","DOI":"10.1039\/c2jm31949g","article-title":"Tetraphenylethene: a versatile AIE building block for the construction of efficient luminescent materials for organic light-emitting diodes","volume":"22","author":"Zhao","year":"2012","journal-title":"J. Mater. Chem."},{"issue":"10","key":"10.1016\/j.biomaterials.2019.119669_bib72","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1039\/b921610c","article-title":"Fluorescent bio\/chemosensors based on silole and tetraphenylethene luminogens with aggregation-induced emission feature","volume":"20","author":"Wang","year":"2010","journal-title":"J. Mater. Chem."},{"issue":"21","key":"10.1016\/j.biomaterials.2019.119669_bib73","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.2174\/0929867325666180226111716","article-title":"Organic fluorescent dye-based nanomaterials: advances in the rational design for imaging and sensing applications","volume":"26","author":"Svechkarev","year":"2019","journal-title":"Curr. Med. Chem."},{"issue":"16","key":"10.1016\/j.biomaterials.2019.119669_bib74","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1039\/C9SC00084D","article-title":"Near-infrared aggregation-induced enhanced electrochemiluminescence from tetraphenylethylene nanocrystals: a new generation of ECL emitters","volume":"10","author":"Liu","year":"2019","journal-title":"Chem. Sci."},{"issue":"43","key":"10.1016\/j.biomaterials.2019.119669_bib75","doi-asserted-by":"crossref","first-page":"17972","DOI":"10.1021\/ja3064588","article-title":"Real-time monitoring of cell apoptosis and drug screening using fluorescent light-up probe with aggregation-induced emission characteristics","volume":"134","author":"Shi","year":"2012","journal-title":"J. Am. Chem. Soc."},{"issue":"26","key":"10.1016\/j.biomaterials.2019.119669_bib76","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1021\/acs.jpca.6b05355","article-title":"Tuning of aggregation enhanced emission and solid state emission from 1,8-naphthalimide derivatives: nanoaggregates, spectra, and DFT calculations","volume":"120","author":"Srivastava","year":"2016","journal-title":"J. Phys. Chem. A"},{"issue":"37","key":"10.1016\/j.biomaterials.2019.119669_bib77","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1021\/jp048475q","article-title":"Aggregation-induced emission of cis,cis-1,2,3,4-tetraphenylbutadiene from restricted intramolecular rotation","volume":"108","author":"Chen","year":"2004","journal-title":"J. Phys. Chem. A"},{"issue":"10101","key":"10.1016\/j.biomaterials.2019.119669_bib78","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0140-6736(17)31917-7","article-title":"Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial","volume":"390","author":"Margolis","year":"2017","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.biomaterials.2019.119669_bib79","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/QAD.0000000000000169","article-title":"Week 48 results from a randomized clinical trial of rilpivirine\/emtricitabine\/tenofovir disoproxil fumarate vs. efavirenz\/emtricitabine\/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adults","volume":"28","author":"Cohen","year":"2014","journal-title":"AIDS"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961219307689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961219307689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:48:40Z","timestamp":1758905320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961219307689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":79,"alternative-id":["S0142961219307689"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119669","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rilpivirine-associated aggregation-induced emission enables cell-based nanoparticle tracking","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119669","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119669"}}